Latest

Coronavirus

Featured Genetics Neuroscience Open Neuroscience Articles

·April 6, 2020·3 min read

Reverse genetic system could accelerate coronavirus research and vaccine development

Using a reverse genetics system, researchers have engineered a labeled version of the SARS-CoV-2, which turns cells green when they become infected with the virus. The technology can significantly help reduce the length of time needed to evaluate developing COVID-19 vaccines and bring them to market sooner.

Featured Neuroscience

·April 6, 2020·3 min read

Anti-clotting drug could reduce ARDS deaths as a result of COVID-19

A new clinical trial is being established to see if anti-clotting drugs, commonly used for heart attack and stroke patients, can help treat COVID-19 patients who develop ARDS. If successful, the tPA drugs could help alleviate the expected ventilator shortage problem we are likely to experience soon.

Featured Neuroscience Open Neuroscience Articles

·April 6, 2020·4 min read

Clinical trials of low-dose rapamycin to protect elderly from COVID-19 proposed

Researchers propose a strategy for repurposing geroprotectors, including rapamycin and metformin, as potential COVID-19 infection prevention methods.

Featured Neuroscience Open Neuroscience Articles

·April 6, 2020·5 min read

A new antiviral drug heading into clinical trials offers hope for COVID-19

EIDD-2801, a new antiviral drug, has the potential to treat coronavirus. A new study reveals the drug can prevent severe lung injury in mouse models and cultured human lung cells infected with COVID-19. The drug will soon be ready for human testing.

Featured Neuroscience Open Neuroscience Articles

·April 6, 2020·2 min read

COVID-19: On average only 6% of actual SARS-CoV-2 infections detected worldwide

Study reveals the official number of confirmed cases of coronavirus is dramatically understated. Data shows, due to insufficient and delayed testing, countries throughout the world have only discovered about 6% of COVID-19 cases. The true number of infections worldwide may already have reached several tens of millions.

Featured Neuroscience Open Neuroscience Articles

·April 6, 2020·4 min read

COVID-19: Self-isolation would dramatically reduce ICU bed demand

Researchers warn that if the US is to avoid the impact on hospitals Italy faces as a result of the coronavirus outbreak, people who are even mildly symptomatic must self isolate to minimize disease transmission.

Featured Neuroscience Neuroscience Videos

·April 5, 2020·5 min read

What the coronavirus does to your body that makes it so deadly

Researchers explore why COVID-19 is more deadly compared to the flu and other viruses.

Featured Neurology Neuroscience Open Neuroscience Articles

·April 5, 2020·2 min read

COVID-19 linked to rare form of encephalitis

A patient who tested positive for COVID-19 developed acute necrotizing encephalitis (ANE) as a result of the coronavirus infection. An MRI scan revealed the patient had lesions in the thalamus and temporal lobes, areas of the brain implicated in consciousness, sensation, and memory function. Researchers advise doctors to look out for COVID-19 patients who present with altered levels of consciousness, as this may be symptomatic of ANE.

Featured Neuroscience Open Neuroscience Articles

·April 4, 2020·4 min read

Study identifies characteristics of patients with fatal COVID-19

Based on data from COVID-19 patients from Wuhan, China, that died as a result of the infection, researchers have identified many symptom commonalities the patients shared.

Featured Neuroscience

·April 4, 2020·4 min read

Clues to COVID-19 coronavirus’s vulnerability emerge from an antibody against SARS

Structural mapping of both SARS and SARS-CoV-2, the virus that causes COVID-19, reveals an almost identical site on both coronaviruses to which the CR3022 antibody binds. This suggests a functionally important and vulnerable site for this family of coronaviruses.

Featured Neuroscience

·April 3, 2020·3 min read

Removing the novel coronavirus from the water cycle

SARS-CoV-2, the virus responsible for COVID-19, can linger for days in sewage and water systems and remain infectious. Researchers call for new studies to determine if current water treatment methods are efficient and effective at killing SARS-CoV-2.

Featured Neuroscience Open Neuroscience Articles

·April 3, 2020·4 min read

Wearing surgical masks in public could help slow COVID-19 pandemic’s advance

Wearing face masks significantly reduced the amounts of airborne virus particles expelled from infected patients. Findings suggest surgical-style face masks could slow the transmission of coronavirus and influenza viruses.

1 … 22 23 24 25 26 … 31

Coronavirus

Reverse genetic system could accelerate coronavirus research and vaccine development

Anti-clotting drug could reduce ARDS deaths as a result of COVID-19

Clinical trials of low-dose rapamycin to protect elderly from COVID-19 proposed

A new antiviral drug heading into clinical trials offers hope for COVID-19

COVID-19: On average only 6% of actual SARS-CoV-2 infections detected worldwide

COVID-19: Self-isolation would dramatically reduce ICU bed demand

What the coronavirus does to your body that makes it so deadly

COVID-19 linked to rare form of encephalitis

Study identifies characteristics of patients with fatal COVID-19

Clues to COVID-19 coronavirus’s vulnerability emerge from an antibody against SARS

Removing the novel coronavirus from the water cycle

Wearing surgical masks in public could help slow COVID-19 pandemic’s advance

Why Human Body Size Leaped 2 Million Years Ago

Accelerated Biological Aging Drives Early-Onset Cancer Risk

Infant Screen Exposure Linked to Lower Future Working Memory

Network Mapping Uncovers 641 Hidden Schizophrenia Risk Genes

Subscribe